Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : The Children's Beverage Group (TCBG) -- Ignore unavailable to you. Want to Upgrade?

To: KSully who wrote (1858)	9/15/1998 8:32:00 AM
From: A66TALLguy	Read Replies (1) \| Respond to of 2452

A reverse merger is simply the process of an entrepreneur or privately-held company, in this case TCBG, becoming public by merging w/ an existing publicly-held company. Usually the existing company, here apparently Savant Biotech according to your information, is basically out of business, a shell company of sorts. The acquiring company, TCBG, changes the focus of the shell...thus, the name change is reflective of the new line of business. BTW, I have no idea who Savant Biotech was, but I can only assume by the name that they were a research company in some start-up biotechnology field...and most likely making no money. This process is generally considered a backdoor approach of taking a company public.